This document summarizes the results of a study investigating vitamin D status in over 24,000 individuals in New South Wales, Australia. The study found:
1) Over 40% of participants had insufficient or deficient vitamin D levels, with the highest rates in spring.
2) Younger women, inpatients, and those in major cities or of lower socioeconomic status were most at risk of deficiency.
3) Factors like being male, living rurally, and higher SES were protective against deficiency.
4) Season, gender, age, location, and SES explained over 30% of the variability in vitamin D levels.
The USPSTF guideline addresses screening for osteoporosis and vitamin D supplementation. For osteoporosis screening, there is convincing evidence that bone measurement tests accurately detect osteoporosis. Clinical risk assessment tools are moderately accurate in identifying risk. One study found screening reduced hip fractures but not other fractures. Drug therapies reduce fractures in women with osteoporosis, but evidence is lacking for men. Potential harms of screening are small. For vitamin D, evidence is insufficient on supplementation to prevent falls in adults, with potential harms including toxicity. More research is needed on screening men for osteoporosis and on vitamin D supplementation.
Vitamin D has effects on bone, muscles, and non-musculoskeletal conditions. It is very common for risk groups like children, older adults, pregnant women, and immigrants to be vitamin D deficient. While vitamin D supplements can help with bone health, the evidence for other benefits is less clear. Large ongoing clinical trials are investigating the effects of vitamin D supplements on conditions like fractures, cardiovascular disease, respiratory infections, diabetes, and cancer. Recommendations for vitamin D intake vary between health organizations.
A 68-year-old woman is concerned about falling and fracturing bones after a friend's injury and asks if vitamin D supplements could help. A review of 4 randomized controlled trials found no evidence that vitamin D reduces fall-related fractures in older adults, and one study found it increased falls. The woman would not likely benefit from vitamin D for fracture prevention based on current evidence.
Raccomandazioni della iof (international osteoporosis foundation) sull’impieg...Merqurio
This position paper from the International Osteoporosis Foundation makes recommendations for vitamin D intake in older adults. Based on randomized controlled trials, daily vitamin D intake of 20-25 μg (800-1000 IU) is estimated to achieve a target serum 25OHD level of 75 nmol/L (30 ng/ml), which is associated with reduced risk of falls and fractures. Higher daily intakes may be needed for those with risk factors like obesity, limited sun exposure, or malabsorption. Doses above 20 μg/day have not been thoroughly evaluated, so higher intakes cannot be generally recommended at this time.
1. The document discusses recommendations from the Dietary Guidelines and MyPyramid for a healthy diet. MyPyramid emphasizes making smart choices from all food groups, balancing food intake with physical activity, and getting optimal nutrition from calories.
2. Key aspects of MyPyramid include recommendations for grains, vegetables, fruits, oils, milk, and meat in daily servings. Foods in each group provide important nutrients. Whole grains, fruits, and vegetables provide fiber, vitamins, and minerals and are linked to reduced disease risk.
3. Tips are provided for including recommended servings from each food group in daily meals and snacks through food preparation and selection strategies. Following MyPyramid guidelines can help individuals achieve a nutritious
1) The study examined the influences of weight status and race/ethnicity on the association between vitamin D intake and serum vitamin D levels in US children aged 1-18 years using NHANES 2005-2006 data.
2) It found that 74% of children did not meet the estimated average requirement for vitamin D intake, and almost 40% had inadequate serum vitamin D levels. Fewer than 20% had optimal vitamin D status.
3) Overweight/obese children and non-Hispanic Black children were more likely to have inadequate vitamin D levels when intake was low, compared to healthy weight and non-Hispanic White children respectively.
This document discusses vitamin D status globally and identifies key factors influencing vitamin D levels around the world. It summarizes data on mean vitamin D levels and deficiencies in various populations and regions. Overall, vitamin D insufficiency is common worldwide, with mean 25(OH)D levels rarely reaching 30 ng/ml. The lowest levels are seen in South Asia, the Middle East, and Africa, influenced by skin pigmentation, cultural factors limiting sun exposure, and season. Other important determinants of vitamin D status include latitude, ethnicity, obesity, and sun exposure behaviors. Fortification policies are important for improving vitamin D levels in some areas.
The USPSTF guideline addresses screening for osteoporosis and vitamin D supplementation. For osteoporosis screening, there is convincing evidence that bone measurement tests accurately detect osteoporosis. Clinical risk assessment tools are moderately accurate in identifying risk. One study found screening reduced hip fractures but not other fractures. Drug therapies reduce fractures in women with osteoporosis, but evidence is lacking for men. Potential harms of screening are small. For vitamin D, evidence is insufficient on supplementation to prevent falls in adults, with potential harms including toxicity. More research is needed on screening men for osteoporosis and on vitamin D supplementation.
Vitamin D has effects on bone, muscles, and non-musculoskeletal conditions. It is very common for risk groups like children, older adults, pregnant women, and immigrants to be vitamin D deficient. While vitamin D supplements can help with bone health, the evidence for other benefits is less clear. Large ongoing clinical trials are investigating the effects of vitamin D supplements on conditions like fractures, cardiovascular disease, respiratory infections, diabetes, and cancer. Recommendations for vitamin D intake vary between health organizations.
A 68-year-old woman is concerned about falling and fracturing bones after a friend's injury and asks if vitamin D supplements could help. A review of 4 randomized controlled trials found no evidence that vitamin D reduces fall-related fractures in older adults, and one study found it increased falls. The woman would not likely benefit from vitamin D for fracture prevention based on current evidence.
Raccomandazioni della iof (international osteoporosis foundation) sull’impieg...Merqurio
This position paper from the International Osteoporosis Foundation makes recommendations for vitamin D intake in older adults. Based on randomized controlled trials, daily vitamin D intake of 20-25 μg (800-1000 IU) is estimated to achieve a target serum 25OHD level of 75 nmol/L (30 ng/ml), which is associated with reduced risk of falls and fractures. Higher daily intakes may be needed for those with risk factors like obesity, limited sun exposure, or malabsorption. Doses above 20 μg/day have not been thoroughly evaluated, so higher intakes cannot be generally recommended at this time.
1. The document discusses recommendations from the Dietary Guidelines and MyPyramid for a healthy diet. MyPyramid emphasizes making smart choices from all food groups, balancing food intake with physical activity, and getting optimal nutrition from calories.
2. Key aspects of MyPyramid include recommendations for grains, vegetables, fruits, oils, milk, and meat in daily servings. Foods in each group provide important nutrients. Whole grains, fruits, and vegetables provide fiber, vitamins, and minerals and are linked to reduced disease risk.
3. Tips are provided for including recommended servings from each food group in daily meals and snacks through food preparation and selection strategies. Following MyPyramid guidelines can help individuals achieve a nutritious
1) The study examined the influences of weight status and race/ethnicity on the association between vitamin D intake and serum vitamin D levels in US children aged 1-18 years using NHANES 2005-2006 data.
2) It found that 74% of children did not meet the estimated average requirement for vitamin D intake, and almost 40% had inadequate serum vitamin D levels. Fewer than 20% had optimal vitamin D status.
3) Overweight/obese children and non-Hispanic Black children were more likely to have inadequate vitamin D levels when intake was low, compared to healthy weight and non-Hispanic White children respectively.
This document discusses vitamin D status globally and identifies key factors influencing vitamin D levels around the world. It summarizes data on mean vitamin D levels and deficiencies in various populations and regions. Overall, vitamin D insufficiency is common worldwide, with mean 25(OH)D levels rarely reaching 30 ng/ml. The lowest levels are seen in South Asia, the Middle East, and Africa, influenced by skin pigmentation, cultural factors limiting sun exposure, and season. Other important determinants of vitamin D status include latitude, ethnicity, obesity, and sun exposure behaviors. Fortification policies are important for improving vitamin D levels in some areas.
This presentation given to the International Society for Enzymology in Corfu details the extent of vitamin D deficiency in the largest state of Australia, NSW. It highlights the over=testing phenomenon that has occurred and how to correct the problem.
Vitamin D status in children with type 1 diabetes mellitusAzad Haleem
The document discusses vitamin D and its role in type 1 diabetes (T1D). It finds that children with T1D have significantly lower levels of vitamin D compared to healthy children. Vitamin D levels were also lower in patients with longer diabetes duration and poorer glycemic control. However, no significant association was found between vitamin D levels and BMI. The document recommends vitamin D supplementation may help improve outcomes for T1D patients and that further research is needed to better understand the relationship between vitamin D and T1D.
introduction to molecular biology of diseases.pptYinebebMezgebu4
This document discusses ageing-related disorders and focuses on biological ageing, global problems of ageing, frailty, dementia, and successful ageing. It provides information on the following key points:
1) Biological ageing is the physiological decline that occurs with chronological age and can be measured using biomarkers of ageing. Factors like telomere length, epigenetic changes, and inflammation are hallmarks of biological ageing.
2) The global population is ageing rapidly which is increasing healthcare costs and societal burden. Many countries now have over 14% of their population aged 75 and over.
3) Frailty is a medical syndrome characterized by decreased reserves and resistance to stressors due
This document discusses the clinical management of elderly patients with diabetes. It addresses several topics:
1. Elderly patients have a different pathophysiology compared to younger adults due to changes in muscle mass, adipose tissue, and vascular function.
2. Elderly patients face higher risks of vascular complications, functional decline, falls and fractures, cognitive impairment, and mortality compared to those without diabetes.
3. A comprehensive assessment of elderly patients with diabetes should consider medical, functional, cognitive, social, and other factors to determine individualized treatment goals that preserve quality of life.
4. The management of elderly diabetes patients should focus on preventing frailty and disability rather than only treating the disease itself. Integrated
Insulin resistance in adults with Type 1 Diabetes is associated with lower wi...Mikołaj Kamiński
Aim of the study: To assess relationship between serum concentrations of 25-hydroxyvitamin D (VD) and insulin resistance (IR) among patients with type 1 diabetes (T1DM(. Conclusions: VD deficiency is frequent among adults with T1DM. Severe VD deficiency increase four times the odds of IR.
Ueda2016 metabolic syndrome in different population,which one is appropriate ...ueda2015
Metabolic syndrome is a cluster of disorders including high blood pressure, high insulin levels, excess body weight, and abnormal cholesterol that increases the risk of diseases like diabetes and heart disease. There is wide variation in the reported prevalence of metabolic syndrome across populations and definitions, and questions remain about its applicability and predictive power equally in all groups. Key determinants include obesity, especially abdominal obesity, and insulin resistance, but genetic and lifestyle factors also contribute to risk.
This document discusses treatment strategies for multiple myeloma, including:
1) Three-drug induction regimens are associated with higher complete response rates than two-drug regimens, though some studies in transplant-eligible patients show improved progression-free survival with two-drug regimens.
2) For transplant-ineligible patients, three-drug regimens containing bortezomib or thalidomide have demonstrated improved overall survival compared to melphalan and prednisone. Whether non-melphalan two-drug combinations can achieve similar outcomes is still under investigation.
3) Risk stratification is increasingly important for determining optimal therapy, though consensus is still lacking on standardized treatment paradigms.
1) Vitamin D plays an important role in muscle strength and performance, especially in the elderly. Studies show that treatment with vitamin D can increase the size and number of type II muscle fibers which are important for strength.
2) Maintaining serum 25(OH)D levels of at least 75 nmol/L through vitamin D3 supplementation of 800-1000 IU per day can reduce the risk of falls and fractures in older adults as well as lower the risk of other chronic diseases.
3) According to studies, a significant portion of the United States population has serum 25(OH)D levels below recommended levels for optimal health benefits. Certain groups like blacks, the elderly, and northerners are particularly
The document discusses vitamin D, what it does, and how much we need. It begins by defining nutrient deficiency and adequacy. It then examines different models for how nutrition is viewed, such as prevention and maintenance for physiologists versus risk avoidance for regulators. The rest of the document reviews evidence that vitamin D deficiency is widespread and has consequences like increased risk of fractures, falls, heart disease, infections, and some cancers. It presents several studies showing benefits of vitamin D for bone health, blood pressure, neuromuscular function, and influenza prevention. The overall message is that vitamin D status is important for overall health and most people have inadequate levels.
The document provides an overview of vitamin D, including its dietary sources, role in bone and overall health, and prevalence of vitamin D deficiency in New Zealand. Key points include:
- Vitamin D status is best determined by measuring 25-hydroxyvitamin D levels in the blood.
- Many New Zealanders, despite a sunny climate, have suboptimal vitamin D levels year-round due to indoor lifestyles.
- Maintaining adequate vitamin D levels may help reduce the risk of osteoporosis, influenza, cancer, cardiovascular disease, and other conditions.
The document discusses recent advances in myelodysplastic syndromes (MDS), including new risk stratification models, prognostic factors, and therapeutic options for lower-risk and higher-risk MDS such as lenalidomide for lower-risk MDS and azacitidine or allogeneic stem cell transplantation for higher-risk MDS. Clinical trials demonstrate that lenalidomide provides significant erythroid responses in lower-risk MDS patients with or without del5q abnormalities, while azacitidine improves overall survival compared
The document discusses recent advances in myelodysplastic syndromes (MDS), including new risk stratification models, prognostic factors, and therapeutic options for lower-risk and higher-risk MDS such as lenalidomide for lower-risk MDS and azacitidine or allogeneic stem cell transplantation for higher-risk MDS. Clinical trials have shown that lenalidomide can induce transfusion independence in patients with MDS and del(5q) abnormality and azacitidine improves overall survival compared to
The Many Faces of Hyperparathyroidism & Advances in TreatmentBabak Larian
Hyperparathyroidism is a rare disease that affects the whole body and can cause potentially debilitating symptoms. Unfortunately, parathyroid disease is often poorly understood, even by parathyroid specialists. Because the signs and symptoms of hyperparathryoidism are similar to other conditions (including aging, stress, depression, menopause, fibromyalgia, etc.), patients are often misdiagnosed. As such, it is Dr Larian's goal to educate both physicians and patients more on the different manifestations of the disease and treatment so that patients can receive the care they deserve.
This presentation - The Many Faces of Hyperparathyroidism & Advances in Treatment - has the following objectives:
1- Understand the physiology of parathyroid disease and the molecular basis for it.
2- Be able to identify the different manifestations of hyperparathyroidism: Typical, Normocalcemic Hyperparathyroidism, and Normohormonal Hyperparathyroidism.
3- Understand the reasoning for the latest recommendations for treatment of disease.
For more information about hyperparathyroid disease and surgery please visit www.ParathyroidMD.com or call 310-461-0300.
Vitamin D plays an important role in bone health and may have protective effects against various diseases. It exists in two main forms, D2 and D3, with D3 being the most common. Vitamin D is obtained through dietary intake, sun exposure, and supplementation. Deficiency is common due to indoor lifestyles and is associated with diseases like rickets. The document discusses challenges in testing vitamin D levels accurately due to matrix effects and differences between assays. A study at a Kuwait hospital found most patients had insufficient vitamin D levels and established a reference range. While testing can provide information, biological activity depends on adequate intake and sun exposure.
This document discusses lipid targets for patients with diabetes and metabolic syndrome. It begins by outlining the major declines in coronary heart disease (CHD) deaths between 1980-2000, attributing about 24% of the decline to lowered cholesterol levels. It then reviews evidence that lowering LDL-C, non-HDL-C, and ApoB reduces cardiovascular risk, with larger reductions associated with greater risk decreases. The document concludes by recommending treatment goals for LDL-C, non-HDL-C, and ApoB for patients at different risk levels according to guidelines from the American Diabetes Association and ADA/ACC consensus statement.
Serum Vitamin D Deficiency is Associated with NASH in AdultsJames Nelson
The aim of this study was to determine the relationship of serum vitamin D levels to histologic features of NAFLD, and associated demographic, clinical, and laboratory data in the well characterized NASH CRN cohort.
This document discusses evidence-based medicine as it relates to official policies on vitamin D. It begins by describing a case study of Heidi, a girl from a story who likely suffered from rickets, weak muscles, and infection due to low vitamin D levels. It then discusses the tolerable upper intake level and approved health effects of vitamin D according to evidence-based medicine and official policies. The professor argues that childhood lack of vitamin D can cause rickets and contracted pelvises, and discusses evidence for vitamin D's role in preventing diseases beyond just rickets.
1) Vitamin D plays an important role in bone metabolism by facilitating calcium absorption in the gut and maintaining calcium and phosphate levels, which are needed for bone mineralization.
2) The recommended daily intake of vitamin D is 600-800 IU for those under age 50 and 800-1000 IU for those over 50, though some studies suggest a minimum of 2000 IU may be needed to achieve optimal vitamin D levels.
3) While sunlight exposure can produce significant amounts of vitamin D, individual factors like skin pigmentation, sunscreen use, and latitude can influence vitamin D production, so measuring vitamin D levels is recommended for those at risk of deficiency.
This talk discusses the physiology of vitamin D and the consequences of vitamin D deficiency. It also presents the evidence for the effects of Vitamin D therapy on Bone density, It also presents the evidence of the effects of vitamin D supplementation on the development of cancer and cardiovascular events
Dyslipidemia 'from guidelines to practice' prof.alaa wafaaalaa wafa
This document discusses guidelines for the treatment of dyslipidemia. It begins by comparing hypertension treatment to lipid lowering, noting that lipid lowering has fewer drug classes, mechanisms of action, and side effects compared to hypertension treatment. It then discusses how many patients do not reach lipid goals even after dose adjustments of statin medications. The document emphasizes the need for more effective cholesterol lowering to meet lipid goals. It reviews various studies demonstrating the relationship between cholesterol levels, cardiovascular risk, and mortality. It discusses the benefits of different statin medications and doses at lowering cholesterol. The document provides an overview of guideline recommendations for cholesterol goals and treatment intensities based on patient risk levels.
Diabetes therapies and technology: implications for doctors and patientsHealthXn
This document summarizes a presentation on diabetes therapies and technology. The presentation discusses:
- The promise and pitfalls of emerging diabetes technologies and ensuring patient safety.
- How the roles of health professionals and patients may change with more connected health solutions and data access.
- The importance of balancing positive and negative hype around new technologies to manage patient expectations.
- Ensuring privacy and security as health data becomes more connected while still providing high-touch patient care.
The future interface of mental health with information technology: high touch...HealthXn
The document discusses the future of mental health and technology, including:
- Technology may help address challenges in healthcare systems but also presents pitfalls if not implemented carefully.
- The roles of health professionals and patients may change as technology becomes more integrated in care, requiring new skills.
- Data and information from various sources can provide insights if analyzed properly, but also raise privacy and security concerns.
- Future health systems will rely more on knowledge management and using data/analytics to provide personalized, predictive care while maintaining the human touch.
More Related Content
Similar to To D or not to D that is the question? Vitamin D deficiency in Australia
This presentation given to the International Society for Enzymology in Corfu details the extent of vitamin D deficiency in the largest state of Australia, NSW. It highlights the over=testing phenomenon that has occurred and how to correct the problem.
Vitamin D status in children with type 1 diabetes mellitusAzad Haleem
The document discusses vitamin D and its role in type 1 diabetes (T1D). It finds that children with T1D have significantly lower levels of vitamin D compared to healthy children. Vitamin D levels were also lower in patients with longer diabetes duration and poorer glycemic control. However, no significant association was found between vitamin D levels and BMI. The document recommends vitamin D supplementation may help improve outcomes for T1D patients and that further research is needed to better understand the relationship between vitamin D and T1D.
introduction to molecular biology of diseases.pptYinebebMezgebu4
This document discusses ageing-related disorders and focuses on biological ageing, global problems of ageing, frailty, dementia, and successful ageing. It provides information on the following key points:
1) Biological ageing is the physiological decline that occurs with chronological age and can be measured using biomarkers of ageing. Factors like telomere length, epigenetic changes, and inflammation are hallmarks of biological ageing.
2) The global population is ageing rapidly which is increasing healthcare costs and societal burden. Many countries now have over 14% of their population aged 75 and over.
3) Frailty is a medical syndrome characterized by decreased reserves and resistance to stressors due
This document discusses the clinical management of elderly patients with diabetes. It addresses several topics:
1. Elderly patients have a different pathophysiology compared to younger adults due to changes in muscle mass, adipose tissue, and vascular function.
2. Elderly patients face higher risks of vascular complications, functional decline, falls and fractures, cognitive impairment, and mortality compared to those without diabetes.
3. A comprehensive assessment of elderly patients with diabetes should consider medical, functional, cognitive, social, and other factors to determine individualized treatment goals that preserve quality of life.
4. The management of elderly diabetes patients should focus on preventing frailty and disability rather than only treating the disease itself. Integrated
Insulin resistance in adults with Type 1 Diabetes is associated with lower wi...Mikołaj Kamiński
Aim of the study: To assess relationship between serum concentrations of 25-hydroxyvitamin D (VD) and insulin resistance (IR) among patients with type 1 diabetes (T1DM(. Conclusions: VD deficiency is frequent among adults with T1DM. Severe VD deficiency increase four times the odds of IR.
Ueda2016 metabolic syndrome in different population,which one is appropriate ...ueda2015
Metabolic syndrome is a cluster of disorders including high blood pressure, high insulin levels, excess body weight, and abnormal cholesterol that increases the risk of diseases like diabetes and heart disease. There is wide variation in the reported prevalence of metabolic syndrome across populations and definitions, and questions remain about its applicability and predictive power equally in all groups. Key determinants include obesity, especially abdominal obesity, and insulin resistance, but genetic and lifestyle factors also contribute to risk.
This document discusses treatment strategies for multiple myeloma, including:
1) Three-drug induction regimens are associated with higher complete response rates than two-drug regimens, though some studies in transplant-eligible patients show improved progression-free survival with two-drug regimens.
2) For transplant-ineligible patients, three-drug regimens containing bortezomib or thalidomide have demonstrated improved overall survival compared to melphalan and prednisone. Whether non-melphalan two-drug combinations can achieve similar outcomes is still under investigation.
3) Risk stratification is increasingly important for determining optimal therapy, though consensus is still lacking on standardized treatment paradigms.
1) Vitamin D plays an important role in muscle strength and performance, especially in the elderly. Studies show that treatment with vitamin D can increase the size and number of type II muscle fibers which are important for strength.
2) Maintaining serum 25(OH)D levels of at least 75 nmol/L through vitamin D3 supplementation of 800-1000 IU per day can reduce the risk of falls and fractures in older adults as well as lower the risk of other chronic diseases.
3) According to studies, a significant portion of the United States population has serum 25(OH)D levels below recommended levels for optimal health benefits. Certain groups like blacks, the elderly, and northerners are particularly
The document discusses vitamin D, what it does, and how much we need. It begins by defining nutrient deficiency and adequacy. It then examines different models for how nutrition is viewed, such as prevention and maintenance for physiologists versus risk avoidance for regulators. The rest of the document reviews evidence that vitamin D deficiency is widespread and has consequences like increased risk of fractures, falls, heart disease, infections, and some cancers. It presents several studies showing benefits of vitamin D for bone health, blood pressure, neuromuscular function, and influenza prevention. The overall message is that vitamin D status is important for overall health and most people have inadequate levels.
The document provides an overview of vitamin D, including its dietary sources, role in bone and overall health, and prevalence of vitamin D deficiency in New Zealand. Key points include:
- Vitamin D status is best determined by measuring 25-hydroxyvitamin D levels in the blood.
- Many New Zealanders, despite a sunny climate, have suboptimal vitamin D levels year-round due to indoor lifestyles.
- Maintaining adequate vitamin D levels may help reduce the risk of osteoporosis, influenza, cancer, cardiovascular disease, and other conditions.
The document discusses recent advances in myelodysplastic syndromes (MDS), including new risk stratification models, prognostic factors, and therapeutic options for lower-risk and higher-risk MDS such as lenalidomide for lower-risk MDS and azacitidine or allogeneic stem cell transplantation for higher-risk MDS. Clinical trials demonstrate that lenalidomide provides significant erythroid responses in lower-risk MDS patients with or without del5q abnormalities, while azacitidine improves overall survival compared
The document discusses recent advances in myelodysplastic syndromes (MDS), including new risk stratification models, prognostic factors, and therapeutic options for lower-risk and higher-risk MDS such as lenalidomide for lower-risk MDS and azacitidine or allogeneic stem cell transplantation for higher-risk MDS. Clinical trials have shown that lenalidomide can induce transfusion independence in patients with MDS and del(5q) abnormality and azacitidine improves overall survival compared to
The Many Faces of Hyperparathyroidism & Advances in TreatmentBabak Larian
Hyperparathyroidism is a rare disease that affects the whole body and can cause potentially debilitating symptoms. Unfortunately, parathyroid disease is often poorly understood, even by parathyroid specialists. Because the signs and symptoms of hyperparathryoidism are similar to other conditions (including aging, stress, depression, menopause, fibromyalgia, etc.), patients are often misdiagnosed. As such, it is Dr Larian's goal to educate both physicians and patients more on the different manifestations of the disease and treatment so that patients can receive the care they deserve.
This presentation - The Many Faces of Hyperparathyroidism & Advances in Treatment - has the following objectives:
1- Understand the physiology of parathyroid disease and the molecular basis for it.
2- Be able to identify the different manifestations of hyperparathyroidism: Typical, Normocalcemic Hyperparathyroidism, and Normohormonal Hyperparathyroidism.
3- Understand the reasoning for the latest recommendations for treatment of disease.
For more information about hyperparathyroid disease and surgery please visit www.ParathyroidMD.com or call 310-461-0300.
Vitamin D plays an important role in bone health and may have protective effects against various diseases. It exists in two main forms, D2 and D3, with D3 being the most common. Vitamin D is obtained through dietary intake, sun exposure, and supplementation. Deficiency is common due to indoor lifestyles and is associated with diseases like rickets. The document discusses challenges in testing vitamin D levels accurately due to matrix effects and differences between assays. A study at a Kuwait hospital found most patients had insufficient vitamin D levels and established a reference range. While testing can provide information, biological activity depends on adequate intake and sun exposure.
This document discusses lipid targets for patients with diabetes and metabolic syndrome. It begins by outlining the major declines in coronary heart disease (CHD) deaths between 1980-2000, attributing about 24% of the decline to lowered cholesterol levels. It then reviews evidence that lowering LDL-C, non-HDL-C, and ApoB reduces cardiovascular risk, with larger reductions associated with greater risk decreases. The document concludes by recommending treatment goals for LDL-C, non-HDL-C, and ApoB for patients at different risk levels according to guidelines from the American Diabetes Association and ADA/ACC consensus statement.
Serum Vitamin D Deficiency is Associated with NASH in AdultsJames Nelson
The aim of this study was to determine the relationship of serum vitamin D levels to histologic features of NAFLD, and associated demographic, clinical, and laboratory data in the well characterized NASH CRN cohort.
This document discusses evidence-based medicine as it relates to official policies on vitamin D. It begins by describing a case study of Heidi, a girl from a story who likely suffered from rickets, weak muscles, and infection due to low vitamin D levels. It then discusses the tolerable upper intake level and approved health effects of vitamin D according to evidence-based medicine and official policies. The professor argues that childhood lack of vitamin D can cause rickets and contracted pelvises, and discusses evidence for vitamin D's role in preventing diseases beyond just rickets.
1) Vitamin D plays an important role in bone metabolism by facilitating calcium absorption in the gut and maintaining calcium and phosphate levels, which are needed for bone mineralization.
2) The recommended daily intake of vitamin D is 600-800 IU for those under age 50 and 800-1000 IU for those over 50, though some studies suggest a minimum of 2000 IU may be needed to achieve optimal vitamin D levels.
3) While sunlight exposure can produce significant amounts of vitamin D, individual factors like skin pigmentation, sunscreen use, and latitude can influence vitamin D production, so measuring vitamin D levels is recommended for those at risk of deficiency.
This talk discusses the physiology of vitamin D and the consequences of vitamin D deficiency. It also presents the evidence for the effects of Vitamin D therapy on Bone density, It also presents the evidence of the effects of vitamin D supplementation on the development of cancer and cardiovascular events
Dyslipidemia 'from guidelines to practice' prof.alaa wafaaalaa wafa
This document discusses guidelines for the treatment of dyslipidemia. It begins by comparing hypertension treatment to lipid lowering, noting that lipid lowering has fewer drug classes, mechanisms of action, and side effects compared to hypertension treatment. It then discusses how many patients do not reach lipid goals even after dose adjustments of statin medications. The document emphasizes the need for more effective cholesterol lowering to meet lipid goals. It reviews various studies demonstrating the relationship between cholesterol levels, cardiovascular risk, and mortality. It discusses the benefits of different statin medications and doses at lowering cholesterol. The document provides an overview of guideline recommendations for cholesterol goals and treatment intensities based on patient risk levels.
Similar to To D or not to D that is the question? Vitamin D deficiency in Australia (20)
Diabetes therapies and technology: implications for doctors and patientsHealthXn
This document summarizes a presentation on diabetes therapies and technology. The presentation discusses:
- The promise and pitfalls of emerging diabetes technologies and ensuring patient safety.
- How the roles of health professionals and patients may change with more connected health solutions and data access.
- The importance of balancing positive and negative hype around new technologies to manage patient expectations.
- Ensuring privacy and security as health data becomes more connected while still providing high-touch patient care.
The future interface of mental health with information technology: high touch...HealthXn
The document discusses the future of mental health and technology, including:
- Technology may help address challenges in healthcare systems but also presents pitfalls if not implemented carefully.
- The roles of health professionals and patients may change as technology becomes more integrated in care, requiring new skills.
- Data and information from various sources can provide insights if analyzed properly, but also raise privacy and security concerns.
- Future health systems will rely more on knowledge management and using data/analytics to provide personalized, predictive care while maintaining the human touch.
Preventing diabetes and obesity in mental health disordersHealthXn
This document summarizes a presentation on preventing diabetes and obesity in patients with mental health issues. It discusses how mental health disorders are associated with higher risks of diabetes and metabolic syndrome due to genetic and lifestyle factors as well as some medications used to treat mental health conditions. Treatment of diabetes and other vascular risk factors is essential for patients with mental health issues since premature death is often due to cardiovascular disease rather than suicide. The presentation emphasizes preventing and early identification of diabetes and metabolic syndrome through lifestyle counseling, monitoring weight and metabolic markers, and treating obesity and diabetes when present.
Iodine and the Thyroid: How the thyroid uniquely adapts to its environment to...HealthXn
This presentation describes how the thyroid actively traps iodine, a rare micronutrient, to produce thyroid hormones. Iodine is important for normal fetal and adult development.
How to prevent Deep Vein Thrombosis when travellingHealthXn
This document provides information and advice on preventing deep vein thrombosis (DVT) during travel. It explains that sitting for long periods of time, such as during flights or car rides, increases the risk of DVT due to limited blood flow. It recommends taking regular breaks to walk around and do leg exercises, staying hydrated, wearing compression stockings, avoiding sleeping pills and alcohol, and discussing aspirin with a doctor for high-risk individuals. Specific exercises are demonstrated to perform during travel to keep blood circulating in the legs and reduce DVT risk.
The value of health information systems and EMR to patient careHealthXn
This presentation given to the Athena Society in Crete documents the challenges and benefits of health information systems and the difficulties encountered in implementing EMR.
Advances in the diagnosis and treatment for benign and malignant thyroid diseaseHealthXn
Thyroid disorders are common. This presentation reviews the causes of benign thyroid disease as well as therapy, including new therapies for advanced thyroid cancer.
Bridging health care’s innovation education gapHealthXn
Recently I was privileged to be part of a consultation bringing together CEOS in health, academia and business to examine health care's innovation education. Regina Herzlinger and co authors have distilled these consultations into this thought provoking article.
https://hbr.org/2014/11/bridging-health-cares-innovation-education-gap
Prevention against micronutrient malnutritionHealthXn
Micronutrident disorders are common and a major cause of morbidity in all populations. In this presentation we discuss the importance of iodine, folic acid and vitamin D deficiency. Prevention is the solution
The impact of maternal and fetal thyroid hormone deficiency: iodine deficienc...HealthXn
Thyroid hormone deficiency at critical periods of brain development may cause permanent mental and neurological disability and impairment. Iodine deficiency is the commonest preventable cause of mental disability
Optimum Healthcare ITA physician’s perspective on Big Data, Predictive Analy...HealthXn
- Big data, predictive analytics, and business intelligence (BI) tools can help healthcare organizations address growing cost pressures and improve operational and financial efficiency. However, their benefits are often underappreciated in healthcare.
- BI can be used for both clinical and non-clinical purposes to analyze large amounts of healthcare data and gain insights. When properly implemented and governed, it allows organizations to better understand variability and optimize performance.
- The presentation will provide real-world examples of how BI is being used in healthcare to improve patient outcomes, safety, and experience as well as hospital operations and systems.
Recent advances in the diagnosis and treatment of thyroid cancerHealthXn
This document summarizes recent advances in the diagnosis and treatment of thyroid cancer by Professor Steven Boyages. It discusses the rising incidence of thyroid cancer in recent decades, which may be due to increased medical surveillance and technology. It describes a study that examined pathways to diagnosis for thyroid cancer patients in New South Wales, finding most were serendipitous discoveries. Factors like tumor size influenced diagnosis pathways. Minimally invasive thyroidectomy techniques and strategies for radioiodine ablation in low-risk thyroid cancer, including using recombinant human thyrotropin and lower radiation doses, are also summarized. Treatment of radioiodine-resistant thyroid cancer is an ongoing challenge.
Value creation in health:investing in people and processHealthXn
This document discusses PulseLearning, a company that provides learning solutions to healthcare clients. It introduces PulseLearning's background, vision, and mission to be a leader in providing healthcare knowledge solutions and improving health outcomes in Australia. The document outlines PulseLearning's value proposition and testimonials from healthcare clients that chose PulseLearning for its understanding of the healthcare sector and ability to deliver accredited training. It also discusses challenges facing the healthcare industry like rising costs, changing patient expectations, and skills gaps. PulseLearning proposes investing in people, processes, and advanced learning technologies to address these challenges and improve teamwork, communication, and patient-centered care.
Performance Management in Health: the role of Health ITHealthXn
The document discusses using large amounts of digital health data and business intelligence tools to monitor performance at various levels - such as systems, providers, patients - to improve quality, experience, and cost effectiveness. It provides examples of monitoring emergency department performance and using public reporting to further improve healthcare systems.
Bottom up approach required for the adoption ofHealthXn
This document discusses key factors for the adoption of electronic health records (EHR) by patients, including needs, benefits, risks, elements of trust, and the approach required. For adoption to be effective, a bottom-up approach is needed that considers patients' needs, the benefits of improved care and outcomes, risks to privacy and safety, and building trust through design, credibility, security, privacy and ease of use of the EHR system.
The big data challenge in healthcare and how can business intelligence best d...HealthXn
This document discusses how big data and business intelligence can help drive critical decision making in healthcare. It notes that big data describes the vast amounts of digital information now stored, and tools like business intelligence can organize and interpret this data to benefit public health, research, patient care, and hospital operations. Business intelligence systems allow leveraging of existing systems, integrating patient and performance data, and providing real-time, predictive and flexible insights. Data from sources like social media, Google trends and analytics can provide information on topics like predicting personality, eating habits, breakups, and flu trends. The document also discusses using data and business intelligence at different layers from the clinical to enterprise level to provide insights and support functions like patient safety, decision making,
The document discusses several apps for health-related purposes including food/weight loss, allergies, fitness, sleep/pulse monitoring, and menstrual cycle tracking. It then summarizes an initiative in New South Wales called "Apps for NSW - Collaborative Solutions for Health" which aims to combine open government data initiatives and business collaboration programs to develop commercially viable mobile health apps. It provides an overview of four challenges that were run under this initiative, with the winning and highly commended apps for areas like medication management, hospital services, and healthcare cycles of care.
4th annual innovation healthcare asia summit panel discussionHealthXn
This document discusses key topics in digital health including mobility systems, virtualization, cloud computing, apps for health, social media, big data systems and analytics, care communication collaboration and coordination, clinical care models, health services, knowledge-based aspects of health, and the role of technology in healthcare. It also examines questions around the changing role of doctors in the digital age, ensuring safety and security of technology, and managing risks associated with digital health.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...rightmanforbloodline
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
To D or not to D that is the question? Vitamin D deficiency in Australia
1. Click to edit Master title style
Click to edit Master title style
2. Click to edit Master title style
Click to edit Master title style
Overview
• Vitamin D status, recommendations and
disease prevention
• Aims
• Methods
• Results
• Outcome and signifance
3. Click to edit Master title style
Click to edit Master title style
Health benefits of vitamin D
• Low 25(OH)D levels linked to
– Osteoporosis and osteopenia
– Cancer
– Diabetes
– Cardiovascular disease
– Autoimmune disease
– Multiple sclerosis
– Respiratory Illness
– Mental Health
4. Click to edit Master title style
Click to edit Master title style
Optimal serum 25(OH)D
Serum 25(OH)D, nmol/L 15 20 25 28 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 140 145
Adapted from Garland CF, Baggerly CA. www.grassrootshealth.org
5. Click to edit Master title style
Click to edit Master title style
Vitamin D intake recommendations
*Recommendations based on maintaining serum vitamin D > 75 nmol/L
(30ng/ml)
Recognition that individuals who are obese or on certain medications be
give 2-3 times more vitamin D
40 IU = 1 µg
Age NHMRC IOM US Endo
Society*
0-1 200 400 1000
1-18 200 600 1000
19-49 200 600 1500-2000
50-69 400 600 1500-2000
70 and over 600 800 1500-2000
6. Click to edit Master title style
Click to edit Master title style
Aims of study
1. Investigate vitamin D status in a large
cohort of individuals residing in NSW
2. Determine the effect of patient setting,
gender, season, remoteness,
socioeconomic status, latitude and
longitude on vitamin D level
7. Click to edit Master title style
Click to edit Master title style
Adequate vitamin D status
Vitamin D (nmol/L*)
Conventional
guidelines
Newer
recommendations+
Severe Deficiency <12.5
Moderate deficiency 12.5-25
Mild deficiency 25-50 <50
Insufficiency 50-75
Sufficiency >50 >75
*2.5 nmol/L = 1 ng/ml
+Bischoff Ferrari, AJCN 2006
8. Click to edit Master title style
Click to edit Master title style
Australian Studies
No. of
subjects
Latitude (0S) Mean
25(OH)D
Prevalence (%) Ref.
<28 nmol/L <50 nmol/L
Overall
VIC 861 38 - 7.2 30.0 Pasco 2001
SE QLD 414 28 69.1 8.0 23.4 McGrath 2001
Winter
SE QLD 28 - 40.5 McGrath 2001
VIC 861 38 59.1 11.3 43.2 Pasco 2001
VIC 287 38 17.6 60.3 Pasco 2004
TAS 404 43 36.2 ~7.4 50.7 Van der Mei
2007
QLD/VIC
/TAS
1669 28-43 67.0/75.5/
51.1
7.1/7.9/
13.0
40.5/37.4/
67.3
Van der Mei
2007 b (pooled
analysis)
9. Click to edit Master title style
Click to edit Master title style
Season and vitamin D status
• Previously assumed enough vitamin D
synthesised and stored for winter requirements
• Half life of vitamin D 1-2 months
• Submariner study showed mean 25(OH)D levels
declined from 78nmol/L to 48 nmol/L in 2 months
in absence of sunlight (P < 0.0001). Diet
included fortified milk and bread
• Other studies show between 40% and 80%
reduction
Dlugos 1995; Veith 1999
10. Click to edit Master title style
Click to edit Master title style
4697
31131 25(OH)D assays
1 July 2008 and 30 July 2010
Primary test, complete data
available for gender, age, patient
setting, date of test, postcode**,
known breast cancer case,
25(OH)D ≤400 nmol/L
Sample type
10839 13979
Diagnostic referral
Outpatient
Private outpatient
Emergency
Inpatient
Private hospital
patient
Public hospital
patient
Private patient
29516
24819
Yes
680618012
Female Male
62016251
Summer Winter
61216245
Autumn Spring
1615
QC sample
Research
Miscellaneous
Unknown
* *Matched
to ARIA,
SEIFA,
Latitude,
Longitude
11. Click to edit Master title style
Click to edit Master title style
Demographics
Patient setting No. (%)
Outpatient 13979 (56.3)
Inpatient 10839 (43.7)
Gender
Female 18012 (72.5)
Male 6806 (27.4)
Season
Summer 6251 (25.2)
Autumn 6245(25.2)
Winter 6201 (25.0)
Spring 6121 (24.7)
Rural and
remoteness index
No. (%)
Major city 16101 (67.3)
Inner regional 3363 (14.1)
Outer regional 3730 (15.6)
Remote 446 (1.9)
Very remote 281 (1.2)
IRSD*
Quintile 1 7507 (31.4)
Quintile 2 4659 (19.9)
Quintile 3 6152 (27.2)
Quintile 4 1944 (8.1)
Quintile 5 3296 (13.8)
*Index of relative socioeconomic disadvantage
12. Click to edit Master title style
Click to edit Master title style
Mean 25(OH)D by gender
74.0
45.1
65.5
43.2
40.0
45.0
50.0
55.0
60.0
65.0
70.0
75.0
Male
Female
45%
reduction
by June
P<.001
37%
reduction
by June
13. Click to edit Master title style
Click to edit Master title style
Mean 25(OH)D by patient setting
70.2
44.9
63.4
42.9
40.0
45.0
50.0
55.0
60.0
65.0
70.0
Ambulatory
subject
Inpatient
P<.001
14. Click to edit Master title style
Click to edit Master title style
79.1
48.6
60.4
42.6
40.0
45.0
50.0
55.0
60.0
65.0
70.0
75.0
80.0
Ambulatory Male
Ambulatory Female
Inpatient Male
Inpatient Female
Supporting Women with Breast
Cancer Today and Every Day
Mean 25(OH)D by gender and
patient setting
15. Click to edit Master title style
Click to edit Master title style
Mean 25(OH)D by age group
*77.0
65.6
40.7
*61.2
40.0
45.0
50.0
55.0
60.0
65.0
70.0
75.0
80.0
<20
20-39
40-59
60-79
≥80
*P<.001
16. Click to edit Master title style
Click to edit Master title style
Mean 25(OH)D by remoteness
0
10
20
30
40
50
60
70
80
Major
cities
Inner
Regional
Outer
Regional
Remote
Australia
Very
Remote
Australia
*66
50
*71
Ambulatory Male
Ambulatory Female
Inpatient male
Inpatient Female
*P<.05
17. Click to edit Master title style
Click to edit Master title style
Vitamin D status
by gender and season
9%
26%
34%
31%
Female Summer
7%
21%
32%
40%
Male Summer
18%
37%
27%
18%
Male Spring
55
%
21%
37%
27%
15%
Female Spring
Severely Deficient
Deficient
Insufficient
Sufficient
58
%
35
%
28
%
18. Click to edit Master title style
Click to edit Master title style
18%
36%
30%
16%
Ambulatory subject Spring
12%
27%
31%
30%
Inpatients Summer
23%
39%
24%
14%
Inpatients Spring
Vitamin D status
by patient setting by season
6%
22%
36%
36%
Ambulatory subject Summer
Severely Deficient
Deficient
Insufficient
Sufficient
54
%
62
%
39
%
28
%
19. Click to edit Master title style
Click to edit Master title style
Vitamin D status for
females from a major city by age
group in spring
0%
5%
10%
15%
20%
25%
30%
35%
40%
Severely
Deficiency
Deficient Insufficient Sufficient
Ambulatory Subject
Deficient
Severely
Deficiency
Deficient Insufficient Sufficient
Inpatient
20-29 years 30-49 years 80 years and over
68.8%62.5%
Deficient
20. Click to edit Master title style
Click to edit Master title style
Vitamin D status in
ambulatory females by
socioeconomic status (IRSD)
*Index of relative socioeconomic disadvantage
0%
5%
10%
15%
20%
25%
30%
35%
40%
Severely
Deficient
Deficient Insufficient Sufficient
Summer
IRSD 1,2
IRSD 9,10
0%
5%
10%
15%
20%
25%
30%
35%
40%
Severely
Deficient
Deficient Insufficient Sufficient
Spring
38.6 vs 21.2
63.0 vs 51.8
21. Click to edit Master title style
Click to edit Master title style
Regression Model
• Serum 25(OH)D controlled for gender, patient
setting, season, age category, remoteness from
capital city, socioeconomic disadvantage.
• Overall regression model explained 31.8% of the
variance (p<0.001)
• Models stratified by gender and patient setting
explained between 26.3 (inpatient females and
33.1% (ambulatory females) of variance
• No effect of latitude or longitude
22. Click to edit Master title style
Click to edit Master title style
Regression model (overall)
95% CI
Inpatient -7.1 -8.0-(-6.3)
Female -3.9 -4.7-(-3.1)
Season
Summer 15.6 14.6-16.6
Autumn 13.9 13.0-15.0
Winter 3.8 2.8-4.9
Age category
<20 7.7 6.1-9.3
40-59 3.0 1.8-4.2
60-79 2.7 1.6-3.8
≥80 1.3 0.1-2.5
ARIA 95% CI
Inner regional 5.2 4.0-6.3
Outer regional 8.8 7.4-10.2
Remote 13.1 8.8-17.5
Very remote 17.4 13.3-21.6
IRSD
3,4 5.9 4.7-7.2
5,6 4.8 3.8-5.8
7,8 5.1 3.6-6.6
9,10 7.9 6.6-9.1
*all P<.001
23. Click to edit Master title style
Click to edit Master title style
Strengths & Limitations
• Size of study, diverse population, ability to
control for month of blood draw, age,
ARIA, IRSD, latitude and longitude
• Non-random sample, inability to control for
other factors that effect vitamin D such as
skin pigmentation, body weight, sunlight
exposure, sun protection habits
24. Click to edit Master title style
Click to edit Master title style
Conclusion
• High prevalence of deficiency in all seasons
but highest in spring
• There is a marked seasonal reduction that
continues into spring
• Particular groups are more at risk of vitamin D
deficiency – young women residing in major
city from lower SES
• Protective factors include living in rural areas,
being male and from a higher SES
25. Click to edit Master title style
Click to edit Master title style
Health Implications
• Public health messages required to address
high prevalence of vitamin D deficiency
• Australians are not adequately
supplementing - suitable guidelines are
required
• Implications regarding frequency and timing
of testing
26. Click to edit Master title style
Click to edit Master title style
Acknowledgements
Westmead Breast Cancer Institute Vitamin D Research Group
John Boyages, (Supervisor, Oncologist, BCI)
Steven Boyages (Supervisor, Endocrinologist, CETI)
Colin Dunstan (Animal Biologist, ANZAC)
Rebecca Mason (Physiologist, Sydney University)
Peter Talbot (Dietitian, Westmead Hospital)
Elisabeth Black (Director of Research, BCI)
Institute of Clinical Pathology and Medical Research
Gary Ma (ICPMR)
27. Table 1. Mean plasma 25(OH)D levels and baseline characteristics for cases and controls.
Umhau JC, George DT, Heaney RP, Lewis MD, et al. (2013) Low Vitamin D Status and Suicide: A Case-Control Study of Active
Duty Military Service Members. PLoS ONE 8(1): e51543. doi:10.1371/journal.pone.0051543
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0051543
28. Table 2. Results of the conditional logistic regression analysis including covariates.
Umhau JC, George DT, Heaney RP, Lewis MD, et al. (2013) Low Vitamin D Status and Suicide: A Case-Control Study of Active
Duty Military Service Members. PLoS ONE 8(1): e51543. doi:10.1371/journal.pone.0051543
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0051543
29. Figure 1. Plot of the computed odds ratios (OR) for the 8 octiles of 25(OH)D concentration, locating
each at the mid-point of the respective octiles.
Umhau JC, George DT, Heaney RP, Lewis MD, et al. (2013) Low Vitamin D Status and Suicide: A Case-Control Study of Active
Duty Military Service Members. PLoS ONE 8(1): e51543. doi:10.1371/journal.pone.0051543
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0051543
30. Figure 2. Plot of the odds ratio for suicide for the top seven octiles, relative to the lowest octile.
Umhau JC, George DT, Heaney RP, Lewis MD, et al. (2013) Low Vitamin D Status and Suicide: A Case-Control Study of Active
Duty Military Service Members. PLoS ONE 8(1): e51543. doi:10.1371/journal.pone.0051543
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0051543
As part of a more specific study we are conducting to understand the relationship between vitamin D status and factors associated with breast cancer prognosis we wanted to assess vitamin D status in the a large population of individuals in and examine the relationship between vitamin D and other environmental factors.
Australian studies to date have been limited. Most have sample sizes or examine vitamin D status in individuals at high risk of deficiency.
All percentages reference a common baseline of 60 nmol/L as shown on the chart.
%’s reflect the disease prevention % at the beginning and ending of available data.
Example: Breast cancer incidence is reduced by 30% when the serum level is 85 nmol/L vs the baseline of 65 nmol/ml. There is an 83% reduction in incidence when the serum level is 125 nmol/L vs the baseline of 25 ng/ml.
The x’s in the bars indicate ‘reasonable extrapolations’ from the data but are beyond existing data.
All Cancers: Lappe JM, et al. Am J Clin Nutr. 2007;85:1586-91. Breast: Garland CF, Gorham ED, Mohr SB, Grant WB, Garland FC. Breast cancer risk according to serum 25-Hydroxyvitamin D: Meta-analysis of Dose-Response (abstract).American Association for Cancer Research Annual Meeting, 2008. Reference serum 25(OH)D was 5 ng/ml. Garland, CF, et al. Amer Assoc Cancer Research Annual Mtg, April 2008,. Colon: Gorham ED, et al. Am J Prev Med. 2007;32:210-6. Diabetes: Hyppönen E, et al. Lancet 2001;358:1500-3. Endometrium: Mohr SB, et al. Prev Med. 2007;45:323-4. Falls: Broe KE, et al. J Am Geriatr Soc. 2007;55:234-9. Fractures: Bischoff-Ferrari HA, et al. JAMA. 2005;293:2257-64. Heart Attack: Giovannucci et al. Arch Intern Med/Vol 168 (No 11) June 9, 2008. Multiple Sclerosis: Munger KL, et al. JAMA. 2006;296:2832-8. Non-Hodgkin’s Lymphoma: Purdue MP, et al. Cancer Causes Control. 2007;18:989-99. Ovary: Tworoger SS, et al. Cancer Epidemiol Biomarkers Prev. 2007;16:783-8. Renal: Mohr SB, et al. Int J Cancer. 2006;119:2705-9. Rickets: Arnaud SB
Based on adequate sunlight exposure
Developed for maintenance of calcium homeostasis and prevention of osteoporosis
Call for new recommendations based on newly discovered actions
As part of a more specific study we are conducting to understand the relationship between vitamin D status and factors associated with breast cancer prognosis we wanted to assess vitamin D status in the a large population of individuals in and examine the relationship between vitamin D and other environmental factors.
Australian studies to date have been limited. Most have sample sizes or examine vitamin D status in individuals at high risk of deficiency.
Limited information on prevalence of Vit D deficiency in Australians, most studies have been in high risk groups
Current recommendations generally focus on bone health in older people. Evidence suggests that vitamin D intakes above current recommendations may be associated with better health outcomes although the optimal level is not known.
The most advantageous serum concentrations of 25(OH)D of 75nmol/L (30ng/mL) are based on factors such as reduction in fractures rates, maximum suppression of PTH and maximum calcium absorption as well as non skeletal outcomes.
An intake of at least 1000 IU is suggested to bring at least 50% of the population up to 75nmol/L
Australian studies have included limited numbers of subjects.
Sunlight 1 MED = 20000 IU
Hands, arms, neck (11%) for 20 minutes in summer early am = 1000 IU
Salmon 160g fillet approx. 530 IU
Fortified cheese slice 55 IU
Regular milk 20 IU
Margarine 12 IU
Multivitamins ave.200 IU
Caltrate with D 400 IU
Specific D ave. 1000IU
Study Design
Explain patient status
Define setting
Aria; SEIFA. latitude obtained from postcode
Based on visual inspection of vitamin D level by age we classified subjects into age groups: <20; 20-39. 40-59, 60-79, ≥80
Inpatients always lower than ambulatory subjects except females in very remote Australia.
See higher percentage of deficiency and severe deficiency in all age groups for both ambulatory and inpatients
Highest percentage of sufficiency in those aged 80 and over
Although it may be a compromise between the negative effects of UVA exposure due to longer durations early and late in the day.
The subjects with serum concentrations of 25-hydroxyvitamin D [25(OH)D] < 40 nmol/L (n = 24) had significantly (P = 0.004) more days of absence from duty due to respiratory infections (median: 4; quartile 1–quartile 3: 2–6) than did controls (2; 0–4; incidence rate ratio: 1.63; 95% CI: 1.15, 2.24; n = 628). The model was adjusted for smoking (n = 169) (Poisson regression analysis).